TGFB1 and cancer: Since TGF-β promoted the formation of immune-excluded tumors by increasing peritumoral collagen production of cancer-associated fibroblast(CAF), recently, YM101 and BiTP were developed to address this issue, which were developed based on the symmetric tetravalency BsAb technology.